Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QH Nutraceuticals is a specialized health and nutrition company primarily focused on the production and distribution of Ubiquinol, the active, non-oxidized form of Coenzyme Q10 (CoQ10). As a subsidiary of Kaneka Corporation, the company leverages proprietary fermentation technology to manufacture high-quality, bioidentical Ubiquinol ingredients for the global dietary supplement and functional food markets. Their business model centers on supplying branded ingredients, most notably Kaneka QH, to other supplement manufacturers and consumer brands. The company provides extensive scientific support and clinical research regarding the benefits of Ubiquinol for cardiovascular health, energy production, and healthy aging. QH Nutraceuticals operates as the primary commercial arm for Kaneka's nutritional ingredients in North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QHNUTRACEUTICALS.